Accelerated Life Science Construction to Meet FDA Standards and Drive Sustainable High-Quality Facilities.

As demand for life-saving therapies surged, life science construction faced mounting pressure in 2025 to navigate supply chain disruptions, meet evolving FDA compliance standards, and deliver sustainable facilities on accelerated timelines. With 70% of projects exceeding budgets and facing delays, driving innovation in project delivery had never been more critical.

That’s why the 3rd annual Advancing Life Science Construction 2025 conference united market experts and industry leaders from trailblazing contractors, clients, and designers to address the most pressing challenges and capitalize on the latest trends that shaped future life science manufacturing and R&D facilities. From preplanning and design through commissioning and turnover, this event explored how to optimize end-to-end project delivery, align projects with technical and regulatory demands, and build more adaptable, sustainable, and compliant facilities for clients.

Whether managing large-scale pharmaceutical manufacturing projects or retrofitting existing spaces, attendees were equipped with actionable insights to streamline collaboration, mitigate risks, and deliver projects on time and on budget.